Pilot Study Comparison of Combigan BID vs Simbrinza TID in Subjects Currently Treated With Latanoprost For Open-Angle Glaucoma or Ocular Hypertension

Next Previous
Trial Profile

Pilot Study Comparison of Combigan BID vs Simbrinza TID in Subjects Currently Treated With Latanoprost For Open-Angle Glaucoma or Ocular Hypertension

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2018

At a glance

  • Drugs Brimonidine/timolol (Primary) ; Brimonidine/brinzolamide
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Therapeutic Use

    • Most Recent Events

    • 14 Mar 2018 Planned End Date changed from 1 Sep 2017 to 1 Apr 2018.
    • 14 Mar 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.
    • 14 Mar 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top